Discontinued — last reported Q2 '25

Other

Deferred compensation plan assets

Edwards Lifesciences Deferred compensation plan assets decreased by 6.9% to $155.50M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ3 2021
Last reportedQ2 2025
Metric ID: other_deferred_compensation_plan_assets

Historical Data

2 periods
 Q4 '25Q1 '26
Value$167.00M$155.50M
QoQ Change—-6.9%
Range$155.50M – $167.00M

Frequently Asked Questions

What is Edwards Lifesciences's deferred compensation plan assets?
Edwards Lifesciences (EW) reported deferred compensation plan assets of $155.50M in Q1 2026.